Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.

Ikeda, Masaomi; Fujita, Tetsuo; Amoh, Yasuyuki; Mii, Sumiyuki; Matsumoto, Kazumasa; Iwamura, Masatsugu

Ikeda, Masaomi; Fujita, Tetsuo; Amoh, Yasuyuki; Mii, Sumiyuki; Matsumoto, Kazumasa; Iwamura, Masatsugu.

Affiliation

Ikeda M; Departments of Urology and Dermatology, Kitasato University School of Medicine, Sagamihara, Japan.

Urol Int ; 91(4): 482-3, 2013.

Article in En | MEDLINE | ID: mdl-23969404

Subject(s)

Carcinoma, Renal Cell/drug therapy; Kidney Neoplasms/drug therapy; Niacinamide/analogs & derivatives; Phenylurea Compounds/adverse effects; Phenylurea Compounds/therapeutic use; Stevens-Johnson Syndrome/pathology; Aged; Betamethasone/therapeutic use; Carcinoma, Renal Cell/complications; Fatal Outcome; Humans; Kidney Neoplasms/complications; Male; Neoplasm Metastasis; Niacinamide/adverse effects; Niacinamide/therapeutic use; Prednisolone/therapeutic use; Sirolimus/analogs & derivatives; Sirolimus/therapeutic use; Skin/drug effects; Sorafenib; Stevens-Johnson Syndrome/complications

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Phenylurea Compounds / Carcinoma, Renal Cell / Stevens-Johnson Syndrome / Niacinamide / Kidney Neoplasms Language: En Journal: Urol Int Year: 2013 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google